sorafenib
bayer
[]
 sorafenib vs. sbrt + sorafenib in #hcc
@ asco-gi 2023 nrg/rtog 1112, 177 pts mos 12,3 vs 15.8 mo mpfs 5.5 vs 9.2 mo no increase of tox, qol benefit sbrt has a role in hcc sora no longer soc -&gt; also an option in combo with io-based therapies? 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision medicine